ImVacS 2014 Distinguished Speaker Faculty
Achim A. Jungbluth, M.D., Ph.D., Director, Immunohistochemistry, Pathology, Memorial Sloan-Kettering Cancer Center
Adam J. Adler, Ph.D., Associate Professor, Immunology, University of Connecticut
Adrian Bot, M.D., Ph.D., Vice President, Translational Medicine, Kite Pharma, Inc.
Adrienne V. Li, Ph.D., Senior Scientist, Vedantra Pharmaceuticals, Inc.
Ana Carrizosa Anderson, Ph.D., Assistant Professor, Neurology, Harvard Medical School
Andrew Geall, Ph.D., RNA Vaccine Platform Leader, Vaccine Delivery & Formulation Research, Novartis Vaccines & Diagnostics, Inc.
Anna-Karin Maltais, Ph.D., CSO, Eurocine Vaccines AB
Bolyn Hubby, Ph.D., Senior Director, Head, Vaccine and Phage R&D, Synthetic Genomics Vaccines, Inc.
Carlos A. Ramos, M.D., Assistant Professor, Medicine, Section of
Cary F. Opel, Researcher, Wittrup Lab, Chemical Engineering, Massachusetts Institute of Technology
Damien Soghoian, Ph.D., Researcher, Virology, Harvard University
Danilo R. Casimiro, Ph.D., Executive Director, Vaccine Research, Merck & Co.
David B. Weiner, Ph.D., Professor, Pathology and Laboratory Medicine, Chair, Gene Therapy and Vaccine Program, CAMB, University of Pennsylvania Perelman School of Medicine
Debraj GuhaThakurta, Ph.D., Director, Computational & Systems Biology, Dendreon Corporation
Denise Faustman, M.D., Ph.D., Director, Immunobiology; Associate Professor, Medicine, Immunobiology, Massachusetts General Hospital & Harvard Medical School
Dirk Brockstedt, Ph.D.,Senior Vice President, Research & Development, Aduro Biotech, Inc
Diviya Sinha, Ph.D., Technical Instructor, Biology, Massachusetts Institute of Technology (MIT)
Dmitry I. Gabrilovich, M.D., Ph.D., Christopher M. Davis Professor, Professor, Translational Tumor Immunology, Wistar Institute
Emma Hickman, Ph.D., Head, Target Validation, Immunocore
Erik L. Hewlett, M.D., Professor, Medicine and of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine
Fabio Bagnoli, Ph.D., Project Leader, Novartis Vaccines and Diagnostics
Graeme Mardon, Ph.D., Professor, Developmental Biology & Pathology, Baylor College of Medicine
Harpreet Singh, Ph.D., Managing Director, CSO, Co-Founder, Immatics Biotechnologies GmbH
Hematology-Oncology, Baylor College of Medicine
Iqbal Grewal, Ph.D., CSO, ImmunGene, Inc.
Jacqueline Doody, Ph.D., Vice President, Immunology, F-star Biotechnology Ltd
J. Robert Coleman, Ph.D., MBA, Co-Founder, Executive Vice President, Vaccine Development, Codagenix, Inc.
James D. Cherry, M.D., M.Sc., Distinguished Research Professor, Pediatrics, David Geffen School of Medicine, UCLA, and Attending Physician, Pediatric Infectious Diseases, Mattel Children’s Hospital
James W. Welsh, M.D., Assistant Professor, Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center
Janice Mehnert, M.D., Medical Oncologist, Cancer Institute of New Jersey
Jason J. Luke, M.D., Instructor, Medicine, Harvard Medical School
Jeff Hutchins, Ph.D., Vice President, Pre-Clinical Development, Peregrine Pharmaceuticals
Joanna E. Brewer, Ph.D., Group Leader, Cellular Biology, Adaptimmune Ltd.
John Hiscott, Ph.D., Program Director, Vaccine & Gene Therapy Institute of Florida
Kai W. Wucherpfennig, M.D., Ph.D., Cancer Immunology & AIDS, Dana-Farber Cancer Institute; Professor of Neurology at Harvard Medical School
Kathy Holtz, Ph.D., Formulation Development Scientist, Protein Sciences Corporation
Laszlo Radvanyi, Ph.D., Professor, Melanoma Medical Oncology - Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Lee M. Wetzler, M.D., Associate Program Director for Research, Infectious Diseases, Professor, Medicine, and Associate Professor, Microbiology, Boston University School of Medicine
Liangfang Zhang, Ph.D., Associate Professor, Nanoengineering and Moores Cancer Center, University of California, San Diego
Li-Fen Lee, Ph.D., Senior Principal Scientist, Rinat, Pfizer
Linda F. Powers, CEO, Chairman of the Board, Northwest Biotherapeutics, Inc.
Liisa K. Selin, M.D., Ph.D., Professor, Pathology, University of Massachusetts Medical School
Llew Keltner, MD, PhD, CEO, EPISTAT
Madi R. Madiyalakan, CEO, Quest PharmaTech
Marc Mansour, Ph.D., COO, ImmunoVaccine
Margaret K. Callahan, M.D., Ph.D., Associate Professor, Medicine, Immunotherapy Clinical Core,Memorial Sloan-Kettering Cancer Center
Mark Bagarazzi, M.D., CMO, Inovio Pharmaceuticals
Mark C. Poznansky, M.D., Ph.D., Associate Professor, Medicine, Harvard Medical School, and Director, Vaccine and Immunotherapy Center, Infectious Diseases Medicine, Massachusetts General Hospital
Mark Szczypka, Ph.D., Senior Director, Applications and New Product Development, Pall Life Sciences
Michael A. Postow, M.D., Assistant Attending Physician, Melanoma and Immunotherapeutics Service, Memorial Sloan-Kettering Cancer Center
Michele Stone, Ph.D., PMP, Director, Vaccines, Liquidia Technologies
Nathalie Garçon, Ph.D., PharmD., Vice President, Head, Global Vaccine Centre for Adjuvants and Technology Innovation, GlaxoSmithKline
Norman W. Baylor, Ph.D., President and CEO, Biologics Consulting Group, Inc.
Ofer Levy, M.D., Ph.D., Senior Associate Physician in Medicine, Boston Children’s Hospital, and Professor, Pediatrics, Harvard Medical School
Omid Hamid, M.D., Director, Melanoma Center, Angeles Clinic and Research Institute
Paul D. Rennert, Founder & Principal, SugarCone Biotech Consultants LLC
Paul F. Robbins, Ph.D., Head, DNA Sequencing and FACS Cores, Surgery Branch; Staff Scientist, Center for Cancer Research, National Cancer Institute
Peter P. Lee, M.D., Billy and Audrey L. Wilder Endowed Professor, Chair, Department of Cancer Immunotherapeutics & Tumor Immunology, City of Hope Comprehensive Cancer Center
Philip R. Dormitzer, M.D., Ph.D., Head, US Research, Global Head of Virology, and Vice President, Novartis Vaccines
Rajan George, Ph.D., President & CSO, Akshaya Bio, Inc.
Rebecca A. Miksad, M.D., MPH, Assistant Professor, Medicine, Harvard Medical School
Richard Morgan, Ph.D., Vice President, Immunotherapy, Bluebird Bio
Robert W. Wilkinson, Ph.D., Director, Oncology Research, MedImmune
Ryan Teague, Ph.D., Assistant Professor, Molecular Microbiology & Immunology, Saint Louis University School of Medicine
Samir Khleif, M.D., Director, GRU Cancer Center; Professor of Medicine, Medical College of Georgia
Seamus Fernandez, Managing Director, Leerink Partners
Sean Du, Ph.D., COO, Altravax, Inc.
Shan Lu, M.D., Ph.D., Professor, University of Massachusetts Medical School
Tarek Fahmy, Ph.D., Associate Professor, Biomedical Engineering, Engineering & Applied Science, Yale University
Taylor Schreiber, M.D., Ph.D., Chairman, Scientific Advisory Board, Pelican Therapeutics
Tod Merkel, Ph.D., Principle Investigator, Laboratory of Respiratory and Special Pathogens, Center for Biologics Evaluation and Research (CBER), FDA
Torsten Dreier, Ph.D., Chief Development Officer, arGEN-X BV, The Netherlands
Vijay K. Kuchroo, DVM, Ph.D., Samuel L. Wasserstrom Professor of Neurology, Harvard Medical School
W. Nicholas Haining, B.M., B.Ch., Assistant Professor of Pediatrics, Harvard Medical School, and Scientific Co-Leader, HSCT Program, Pediatric Oncology, Dana-Farber Cancer Institute Children’s Hospital, and Associate Member, Broad Institute of Harvard and MIT
Weiming Yuan, Ph.D., Assistant Professor, Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California
William M. Egan, Ph.D., Senior Expert, Novartis Vaccines & Diagnostics
Yoav Peretz, Ph.D., Scientific Director, Immunology, ImmuneCarta, Caprion
Yongqun (Oliver) He, D.V.M., Ph.D., Associate Professor, Microbiology and Immunology, Affiliated Member, Center for Computational Medicine and Biology (CCMB), Member, Comprehensive Cancer Center, University of Michigan
Zelig Eshhar, Ph.D., Professor, Immunology, The Weizmann Institute of Science